These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 982475)

  • 1. Protection against sea snake envenomation: comparative potency of four antivenenes.
    Baxter EH; Gallichio HA
    Toxicon; 1976 Aug; 14(5):347-55. PubMed ID: 982475
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-neutralization by tiger snake (Notechis scutatus) antivenene and sea snake (Enhydrina schistosa) antivenene against several sea snake venoms.
    Baxter EH; Gallichio HA
    Toxicon; 1974 May; 12(3):273-8. PubMed ID: 4218381
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunological studies on an Egyptian bivalent Naja antivenin.
    Mohamed AH; Darwish MA; Hani-Ayobe M
    Toxicon; 1974 May; 12(3):321-3. PubMed ID: 4458113
    [No Abstract]   [Full Text] [Related]  

  • 4. Neutralization of old world viper venoms by American pit viper antivenin.
    Minton SA
    Toxicon; 1976; 14(2):146-8. PubMed ID: 1273862
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on Egyptian Cerastes cerastes antivenin.
    Mohamed AH; Darwish MA; Hani-Ayobe M
    Toxicon; 1974 Dec; 12(6):599-601. PubMed ID: 4218382
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunological studies on polyvalent and monovalent snake antivenins.
    Mohamed AH; Khalil FK; Baset AA
    Toxicon; 1977; 15(4):271-5. PubMed ID: 407671
    [No Abstract]   [Full Text] [Related]  

  • 7. Cross neutralization of dangerous snake venoms from Africa and the Middle East using the VACSERA polyvalent antivenom. Egyptian Organization for Biological Products & Vaccines.
    Seddik SS; Wanas S; Helmy MH; Hashem M
    J Nat Toxins; 2002 Dec; 11(4):329-35. PubMed ID: 12503876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The production and characteristics of a coral snake (Micrurus mipartitus Hertwigi) antivenin.
    Bolaños R; Cerdas L; Taylor R
    Toxicon; 1975 Mar; 13(2):139-42. PubMed ID: 1129821
    [No Abstract]   [Full Text] [Related]  

  • 9. Antihaemolytic and snake venom neutralizing effect of some Indian medicinal plants.
    Kumarapppan C; Jaswanth A; Kumarasunderi K
    Asian Pac J Trop Med; 2011 Sep; 4(9):743-7. PubMed ID: 21967700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical assessment of the neutralizing efficacy of snake antivenoms in Latin America and the Caribbean: A review.
    Gutiérrez JM
    Toxicon; 2018 May; 146():138-150. PubMed ID: 29510161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antivenom cross-neutralization of the venoms of Hydrophis schistosus and Hydrophis curtus, two common sea snakes in Malaysian waters.
    Tan CH; Tan NH; Tan KY; Kwong KO
    Toxins (Basel); 2015 Feb; 7(2):572-81. PubMed ID: 25690691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme-linked immunosorbent assay (ELISA) in assessing antivenom potency.
    Theakston RD; Reid HA
    Toxicon; 1979; 17(5):511-5. PubMed ID: 516083
    [No Abstract]   [Full Text] [Related]  

  • 13. Functional Application of Snake Venom Proteomics in In Vivo Antivenom Assessment.
    Tan CH; Tan KY
    Methods Mol Biol; 2019; 1871():153-158. PubMed ID: 30276739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumescent contravenom: murine model for prehospital treatment of Naja naja neurotoxic snake envenomation.
    Makdisi JR; Kim DP; Klein PA; Klein JA
    Int J Dermatol; 2018 May; 57(5):605-610. PubMed ID: 29460967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the preclinical efficacy of antivenoms: from the lethality neutralization assay to antivenomics.
    Gutiérrez JM; Solano G; Pla D; Herrera M; Segura Á; Villalta M; Vargas M; Sanz L; Lomonte B; Calvete JJ; León G
    Toxicon; 2013 Jul; 69():168-79. PubMed ID: 23201503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross neutralisation of Southeast Asian cobra and krait venoms by Indian polyvalent antivenoms.
    Leong PK; Tan NH; Fung SY; Sim SM
    Trans R Soc Trop Med Hyg; 2012 Dec; 106(12):731-7. PubMed ID: 23062608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current technology for the industrial manufacture of snake antivenoms.
    León G; Vargas M; Segura Á; Herrera M; Villalta M; Sánchez A; Solano G; Gómez A; Sánchez M; Estrada R; Gutiérrez JM
    Toxicon; 2018 Sep; 151():63-73. PubMed ID: 29959968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological studies on scorpion (B. quinquestriatus) antivenin.
    Mohamed AH; Darwish MA; Hani-Ayobe M
    Toxicon; 1975 Feb; 13(1):67-8. PubMed ID: 1052563
    [No Abstract]   [Full Text] [Related]  

  • 19. Resistance of warm-blooded animals to snake venoms.
    Perez JC; Haws WC; Garcia VE; Jennings BM
    Toxicon; 1978; 16(4):375-83. PubMed ID: 684768
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of dimethyl sulfoxide on snake venom toxicity in vivo and on the efficacy of antivenins.
    Tiru-Chelvam R
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):1033-8. PubMed ID: 4214660
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.